153 related articles for article (PubMed ID: 24970027)
1. Lin28/let-7/Bcl-xL pathway: the underlying mechanism of drug resistance in Hep3B cells.
Tian N; Han Z; Li Z; Zhou M; Fan C
Oncol Rep; 2014 Sep; 32(3):1050-6. PubMed ID: 24970027
[TBL] [Abstract][Full Text] [Related]
2. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.
Shimizu S; Takehara T; Hikita H; Kodama T; Miyagi T; Hosui A; Tatsumi T; Ishida H; Noda T; Nagano H; Doki Y; Mori M; Hayashi N
J Hepatol; 2010 May; 52(5):698-704. PubMed ID: 20347499
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-sensitization enhanced by curcumin involves down-regulation of nuclear factor-κB and Lin28 in Hep3B cells.
Zhou M; Li Z; Han Z; Tian N
J Recept Signal Transduct Res; 2015; 35(6):618-25. PubMed ID: 26108226
[TBL] [Abstract][Full Text] [Related]
4. Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.
Lv K; Liu L; Wang L; Yu J; Liu X; Cheng Y; Dong M; Teng R; Wu L; Fu P; Deng W; Hu W; Teng L
PLoS One; 2012; 7(7):e40008. PubMed ID: 22808086
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance.
Meng W; Tai Y; Zhao H; Fu B; Zhang T; Liu W; Li H; Yang Y; Zhang Q; Feng Y; Chen G
Med Sci Monit; 2017 Mar; 23():1295-1304. PubMed ID: 28291769
[TBL] [Abstract][Full Text] [Related]
6. Let-7b binding site polymorphism in the B-cell lymphoma-extra large 3'UTR is associated with fluorouracil resistance of hepatocellular carcinoma.
Ma J; Guo R; Wang T; Pan X; Lei X
Mol Med Rep; 2015 Jan; 11(1):677-81. PubMed ID: 25333670
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells.
Chun E; Lee KY
Biochem Biophys Res Commun; 2004 Mar; 315(3):771-9. PubMed ID: 14975768
[TBL] [Abstract][Full Text] [Related]
9. Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.
Yin J; Zhao J; Hu W; Yang G; Yu H; Wang R; Wang L; Zhang G; Fu W; Dai L; Li W; Liao B; Zhang S
PLoS One; 2017; 12(2):e0172787. PubMed ID: 28235063
[TBL] [Abstract][Full Text] [Related]
10. Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma.
Miao J; Chen GG; Chun SY; Chak EC; Lai PB
Int J Oncol; 2004 Sep; 25(3):651-9. PubMed ID: 15289866
[TBL] [Abstract][Full Text] [Related]
11. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
Qin J; Luo M; Qian H; Chen W
Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis.
Yang N; Zhang H; Si-Ma H; Fu Y; Zhao W; Li D; Yang G
Hepatogastroenterology; 2011; 58(110-111):1730-5. PubMed ID: 21940343
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolidine dithiocarbamate reverses Bcl-xL-mediated apoptotic resistance to doxorubicin by inducing paraptosis.
Park SS; Lee DM; Lim JH; Lee D; Park SJ; Kim HM; Sohn S; Yoon G; Eom YW; Jeong SY; Choi EK; Choi KS
Carcinogenesis; 2018 Mar; 39(3):458-470. PubMed ID: 29329420
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.
Ou Y; Zhai D; Wu N; Li X
Gene; 2015 Nov; 572(1):116-122. PubMed ID: 26143754
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma.
Lau CK; Yang ZF; Lam SP; Lam CT; Ngai P; Tam KH; Poon RT; Fan ST
Cancer Biol Ther; 2007 Dec; 6(12):1900-7. PubMed ID: 18059167
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma.
Huang Y; Chen G; Wang Y; He R; Du J; Jiao X; Tai Q
Biochem Biophys Res Commun; 2018 Sep; 503(2):1035-1041. PubMed ID: 29935185
[TBL] [Abstract][Full Text] [Related]
17. Etoposide induces a mixed type of programmed cell death and overcomes the resistance conferred by Bcl-2 in Hep3B hepatoma cells.
Yoo SH; Yoon YG; Lee JS; Song YS; Oh JS; Park BS; Kwon TK; Park C; Choi YH; Yoo YH
Int J Oncol; 2012 Oct; 41(4):1443-54. PubMed ID: 22895528
[TBL] [Abstract][Full Text] [Related]
18. Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
Mei N; Zhao N; Tian T; Jiao M; Li C
Pharmacol Res Perspect; 2021 Feb; 9(1):e00715. PubMed ID: 33486902
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.
Miyata M; Morishita A; Sakamoto T; Katsura A; Kato K; Nishioka T; Toyota Y; Fujita K; Maeda E; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Fujiwara S; Nishiyama N; Iwama H; Himoto T; Hirashima M; Masaki T
Int J Oncol; 2015 Aug; 47(2):535-42. PubMed ID: 26060089
[TBL] [Abstract][Full Text] [Related]
20. MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells.
Chen Y; Feng F; Gao X; Wang C; Sun H; Zhang C; Zeng Z; Lu Y; An L; Qu J; Wang F; Yang Y
Curr Cancer Drug Targets; 2015; 15(3):176-87. PubMed ID: 25714700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
